Design, synthesis and biological evaluation of tyrosinase-targeting PROTACs

Lin, 2007, Melanocyte biology and skin pigmentation, Nature, 445, 843, 10.1038/nature05660

Moreiras, 2020, The exocyst is required for melanin exocytosis from melanocytes and transfer to keratinocytes, Pigm. Cell. Melanoma. R., 33, 366, 10.1111/pcmr.12840

Pillaiyar, 2018, Inhibitors of melanogenesis: an updated review, J. Med. Chem., 61, 7395, 10.1021/acs.jmedchem.7b00967

Sorg, 2017, Skin wound healing: an update on the current knowledge and concepts, Eur. Surg. Res., 58, 81, 10.1159/000454919

Bae-Harboe, 2012, Tyrosinase: a central regulatory protein for cutaneous pigmentation, J. Invest. Dermatol., 132, 2678, 10.1038/jid.2012.324

Slominski, 2012, L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions, Pigm. Cell. Melanoma. R., 25, 14, 10.1111/j.1755-148X.2011.00898.x

Pillaiyar, 2017, Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors, J. Enzym. Inhib. Med. Chem., 32, 403, 10.1080/14756366.2016.1256882

Haudecoeur, 2017, 2-Hydroxypyridine-N-oxide-Embedded aurones as potent human tyrosinase inhibitors, ACS Med. Chem. Lett., 8, 55, 10.1021/acsmedchemlett.6b00369

Mann, 2018, Inhibition of human tyrosinase requires molecular motifs distinctively different from mushroom tyrosinase, J. Invest. Dermatol., 138, 1601, 10.1016/j.jid.2018.01.019

Roulier, 2020, Advances in the design of genuine human tyrosinase inhibitors for targeting melanogenesis and related pigmentations, J. Med. Chem., 63, 13428, 10.1021/acs.jmedchem.0c00994

Kim, 2017, Increased skin irritation by hydroquinone and rsetinoic acid used in combination, Ann. Dermatol., 29, 715, 10.5021/ad.2017.29.6.715

Owolabi, 2020, Effects of skin lightning cream agents - hydroquinone and kojic acid, on the skin of adult female experimental rats, Clin. Cosmet. Invest. Dermatol., 13, 283, 10.2147/CCID.S233185

Bang, 2008, Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity, J. Cosmet. Dermatol., 7, 189, 10.1111/j.1473-2165.2008.00387.x

Zhou, 2009, Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells, Mol. Pharmacol., 76, 579, 10.1124/mol.109.057323

Spínola, 2013, Effect of time and temperature on vitamin C stability in horticultural extracts. UHPLC-PDA vs iodometric titration as analytical methods, LWT - Food Sci. Technol. (Lebensmittel-Wissenschaft -Technol.), 50, 489, 10.1016/j.lwt.2012.08.020

Arulmozhi, 2013, Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB), Colloids Surf., B, 110, 313, 10.1016/j.colsurfb.2013.03.039

Tse, 2012, Tranexamic acid: an important adjuvant in the treatment of melasma, J. Cosmet. Dermatol., 12, 57, 10.1111/jocd.12026

Ladizinski, 2011, Widespread use of toxic skin lightning compounds: medical and psychosocial aspects, Dermatol. Clin., 29, 111, 10.1016/j.det.2010.08.010

Masub, 2020, Cosmetic skin lightning use and side effects, J. Dermatol. Treat., 31, 1

Burslem, 2020, Proteolysis-targeting chimeras as therapeutics and tools for biological discovery, Cell Commun. Signal., 181, 102

Neklesa, 2017, Targeted protein degradation by PROTACs, Pharmacol. Ther., 174, 138, 10.1016/j.pharmthera.2017.02.027

Schapira, 2019, Targeted protein degradation: expanding the toolbox, Nat. Rev. Drug Discov., 18, 949, 10.1038/s41573-019-0047-y

Pettersson, 2019, PROteolysis TArgeting Chimeras (PROTACs) - past, present and future, Drug Discov. Today Technol., 31, 15, 10.1016/j.ddtec.2019.01.002

Benowitz, 2021, The therapeutic potential of PROTACs, Expert Opin. Ther. Pat., 31, 1, 10.1080/13543776.2021.1840553

Kim, 2012, Enhancement of commercial antifungal agents by Kojic acid, Int. J. Mol. Sci., 13, 13867, 10.3390/ijms131113867

Noh, 2009, Kojic acid-amino acid conjugates as tyrosinase inhibitors, Bioorg, Med. Chem. Lett., 19, 5586, 10.1016/j.bmcl.2009.08.041

Deri, 2016, The unravelling of the complex pattern of tyrosinase inhibition, Sci. Rep., 6, 34993, 10.1038/srep34993

Ishida, 2020, E3 ligase ligands for PROTACs: how they were found and how to discover new ones, SLAS. Discov., 25, 1

Fischer, 2014, Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide, Nature, 512, 49, 10.1038/nature13527

Zorba, 2018, Delineating the role of cooperativity in the design of potent PROTACs for BTK, Proc. Natl. Acad. Sci. U.S.A., 115, 7285, 10.1073/pnas.1803662115

Munoz-Munoz, 2010, Tyrosinase inactivation in its action on dopa, Biochim. Biophys. Acta, 1804, 1467, 10.1016/j.bbapap.2010.02.015

Goldfeder, 2014, Determination of tyrosinase substrate-binding modes reveals mechanistic differences between type-3 copper proteins, Nat. Commun., 5, 4505, 10.1038/ncomms5505

Newton, 2017, JAK2 JH2 fluorescence polarization assay and crystal structures for complexes with three small molecules, ACS Med. Chem. Lett., 8, 614, 10.1021/acsmedchemlett.7b00154

Chagraoui, 2019, L-DOPA in Parkinson's disease: looking at the "false" neurotransmitters and their meaning, Int. J. Mol. Sci., 21, 294, 10.3390/ijms21010294

Antonio D S, 2011, An overview of trends for improving Parkinson's disease treatment, Curr. Pharmaceut. Des., 17, 3482, 10.2174/138161211798194495

Misu, 1993, Is l-dopa an endogenous neurotransmitter?, Trends, Pharmacol. Sci., 14, 119

Hale, 2002, Zinc-2-glycoprotein regulates melanin production by normal and malignant melanocytes, J. Invest. Dermatol., 119, 464, 10.1046/j.1523-1747.2002.01813.x

White, 2008, Transparent adult zebrafish as a tool for in vivo transplantation analysis, Cell. Stem. Cell., 2, 183, 10.1016/j.stem.2007.11.002

Camp, 2001, Tyrosinase gene expression in zebrafish embryos, Dev. Gene. Evol., 211, 150, 10.1007/s004270000125

Page-McCaw, 2004, Retinal network adaptation to bright light requires tyrosinase, Nat. Neurosci., 7, 1329, 10.1038/nn1344

Lamason, 2005, SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans, Science, 310, 1782, 10.1126/science.1116238

Cheng, 2016, Identification of a small molecule that downregulates MITF expression and mediates antimelanoma activity in vitro, Melanoma Res., 26, 117, 10.1097/CMR.0000000000000229

Kaufman, 2009, Chemical genetic screening in the zebrafish embryo, Nat. Protoc., 4, 1422, 10.1038/nprot.2009.144

Taylor, 2010, Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads, Cell Commun. Signal., 8, 11, 10.1186/1478-811X-8-11

Raza, 2020, Bioorg. Chem., 94, 103445, 10.1016/j.bioorg.2019.103445

Buhimschi, 2018, Targeting the C481S ibrutinib-resistance mutation in bruton's tyrosine kinase using PROTAC-mediated degradation, Biochemistry, 57, 3564, 10.1021/acs.biochem.8b00391

Brownell, 2010, Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ, Mol. Cell., 37, 102, 10.1016/j.molcel.2009.12.024

Hu, 2020, Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1, Acta, Der Pharm. Sin. B., 10, 1943, 10.1016/j.apsb.2020.02.010

Sun, 2018, PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies, Cell Res., 28, 779, 10.1038/s41422-018-0055-1

Wang, 2020, Degradation of proteins by PROTACs and other strategies, Acta Pharm. Sin. B., 10, 207, 10.1016/j.apsb.2019.08.001

Fenoll, 2002, Kinetic characterisation of the reaction mechanism of mushroom tyrosinase on tyramine/dopamine and L-tyrosine methyl esther/L-dopa methyl esther, Int. J. Biochem. Cell Biol., 34, 1594, 10.1016/S1357-2725(02)00076-6

Favre, 2014, Modeling the met form of human tyrosinase: a refined and hydrated pocket for antagonist design, Chem. Biol. Drug Des., 84, 206, 10.1111/cbdd.12306

Razzaghi-Asl, 2013, Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors, Bioorg, Med. Chem., 21, 6893

Sun, 2021, Kojic acid in fourteen mono-solvents: solubility data, Hansen solubility parameter and thermodynamic properties, J. Chem. Thermodyn., 152, 106280, 10.1016/j.jct.2020.106280

Bala, 2006, Analytical methods for assay of ellagic acid and its solubility studies, J. Pharmaceut. Biomed. Anal., 40, 206, 10.1016/j.jpba.2005.07.006

Leite, 2018, Microemulsions as platforms for transdermal delivery of hydrophilic drugs - a review, Curr. Nanosci., 14, 170, 10.2174/1573413714666171218145416

Zhang, 2020, Codelivery of hydrophilic and hydrophobic drugs in a microneedle patch for the treatment of skin pigmentation, J. Ind. Eng. Chem., 88, 241, 10.1016/j.jiec.2020.04.019